The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance-Reference-Cited by-同舟云学术

The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance

Published:2013-11-22 Issue:1 Volume:32 Page:47-61
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Frederix Gerardus W. J.,van Hasselt Johan G. C.,Schellens Jan H. M.,Hövels Anke M.,Raaijmakers Jan A. M.,Huitema Alwin D. R.,Severens Johan L.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-013-0106-x.pdf

Reference58 articles.

1. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–6. Value Health. 2012;15(6):835–42.

2. Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 1999;319(7210):635–8.

3. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9 . Accessed 3 Oct 2013.

4. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet. 2002;360(9334):711–5.

5. Spiegelhalter DJ, Best NG. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med. 2003;22(23):3687–709.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing;Medical Decision Making;2024-08-02

2. A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus;PharmacoEconomics;2023-09-22

3. Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review;The European Journal of Health Economics;2022-07-05

4. How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea;Frontiers in Pharmacology;2022-05-16

5. Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease;PLOS ONE;2022-04-28